EGFR and lung carcinoma: Moreover, a global decrease in H3K27me3 or accumulation of H3K9me3 has been observed in triple-negative breast cancer cells after chemotherapy and in lung cancer cells after treatment with a tyrosine kinase inhibitor of the EGFR, respectively.